PFE

Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs · BCBA:PFE

12,630.00 ARS330.00 +2.68%

Pfizer Inc Shs Cert Deposito Arg Repr 0.25 Shs (BCBA:PFE) last traded at 12,630.00 ARS, up 2.68% on the day. Over the past year the stock is up 39.87%. Its 52-week range is 8,800.00 to 12,740.00. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open12,540.00

Day range12,470.00 – 12,740.00

52-week range8,800.00 – 12,740.00

Volume468.93 K

Average volume (10 days)69.08 K

Market cap (USD)173.95 B

P/E50.00

EPS (TTM) (USD)0.1700

Dividend yield3.36%

Beta (1 year)−0.0726

Revenue (TTM) (USD)59.92 B

Employees75.00 K

Performance

+1.85%1 week

+9.54%1 month

+30.21%3 months

+28.42%6 months

+32.95%Year to date

+39.87%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Latest headlines

Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week — Barrons.comDow Jones Newswires · 01 Nov 2026
What To Expect In Markets This Week: AAPL, PLTR, AMD, SMCI, SHOP, Earnings, Jobs Report And MoreStocktwits · 01 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Big Homes, Big Loans — Barrons.comDow Jones Newswires · 30 Oct 2026
Catalyst watch: Election drama, jobs report, Apple and McDonald's in the earnings confessionalSeeking Alpha · 30 Oct 2026
A Big Tech Selloff and Crypto Heist to Start the Day. Next Week Brings Apple Earnings and Midterms. — Barrons.comDow Jones Newswires · 30 Oct 2026
Edison Scientific Announces Agreement With Pfizer To Accelerate Research And DevelopmentReuters · 29 Oct 2026
Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmarkMint · 29 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.